Picato
(ingenol mebutate 0.015%)Small molecule
LEO Pharma0
Indications
3
Total Trials
0
Active Trials
0
Competitors
1
FDA Application
NDA/BLA/ANDA regulatory filings
12
Patents
Clinical
Trials by Indication[1]
Regulatory
FDA Approval Timeline[3]
Jan 23, 2012
PICATO
NDA NDA202833
Sources
References
- [1]
- [2]
- [3]
- [4]FDA Orange Book — Patent and exclusivity data for Picato. U.S. Food & Drug Administration.
- [5]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Company